NLRP3 and atherosclerosis: A plethora of information, resulting from the analysis of rodent and human atherosclerotic plaques, has demonstrated that IL-1β and IL-18, both of which are products of the NLRP3 inflammasome activation, play a key role in the initiation and progression of atherosclerosis.